Revelation Biosciences, Inc. (REVB) KPIs and segments

REVBNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as REVBW

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30

$4.26−0.12 (-2.63%)

Close on Nov 13, 2026Market cap $2.91MP/E –Yield –

KPIs & segments

Operating metrics and segments that drive Revelation Biosciences's business

Coming soon

This tab will track the numbers specific to Revelation Biosciences's business model — such as store count, revenue by banner, revenue per store and new openings — taken from filings and earnings releases.

See a number that looks wrong?